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Auditory screening and early identification and management of patients with hearing loss improve 
the development prospects of infants.
Objective: To analyze the outcomes produced by an Auditory Health Program in neonates managed 
in an intensive care unit.
Method: This prospective cross-sectional study enrolled neonates referred to the neonatal care unit 
at hospital CAISM/Unicamp with stays lasting for 48 hours and more within a period of 13 months. 
Automated monitoring of brainstem auditory evoked potentials was used in the auditory screening 
of neonates at the time of discharge. Children with poor BAEPs were sent to undergo audiological, 
otorhinolaryngological, and genetic tests.
Results: Auditory screening was performed for 84.7% of the live births; 39.7% were screened at 
30 days or more of age. Diagnostic tests revealed that 63.8% of the children had normal hearing. 
Incidence of hearing loss was 4%; sensorineural hearing loss was observed in 1.4% of the subjects; 
0.24% had auditory neuropathy spectrum disorder; and 2.2% had conductive hearing loss.
Conclusion: Neonatal auditory screening was not offered universally, and nor was it carried out, in 
many cases, within the child’s first month of life. Screening must be performed before neonates are 
discharged and in more than one stage. A high incidence of hearing loss was observed.
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INTRODUCTION
Mortality rates in high-risk neonates have 
progressively dropped due to the advances in 
technology in neonatal intensive care units (ICU), 
medical devices, drugs, and the growing number of 
medical professionals specialized in this area.
The advances in neonatology have led to higher 
survival rates among preterm low-weight babies. 
However, health care workers have been increasingly 
concerned with the quality of life these neonates will 
enjoy, as sequelae often set in after discharge.
Hearing loss is a frequent alteration in children 
seen in neonatal ICUs, with incidences ranging between 
1% and 4% in this population1,2.
Sensory deprivation consequent to hearing 
loss, specifically in the early stages of language 
acquisition, introduces significant barriers to the overall 
development of the affected children3. Hearing loss may 
lead to deficits in language acquisition and cognitive, 
intellectual, cultural, and social impairment.
Universal neonatal auditory screening has been 
recommended as the main strategy to reduce the age 
at which hearing loss is diagnosed1. Early diagnosis 
followed by medical intervention and speech and 
hearing therapy enable children to have contact with 
sound stimuli while there still is significant plasticity in 
their central nervous systems (in their first year of life), 
thus allowing the development of nerve connections 
and improved outcomes in auditory rehabilitation and 
the overall development of children with hearing loss4,5.
The Neonatal Auditory Health Program 
encompasses a set of actions involving universal 
auditory screening for neonates accompanied by speech 
and hearing, otorhinolaryngological, and genetic tests 
for the subjects singled out during screening or speech 
and hearing tests. When performed early on, these 
procedures may improve patient development.
Few studies have addressed the outcomes of 
children in need of intensive care.
Therefore, this study aimed to analyze the 
outcomes produced by an Auditory Health Program 
including auditory screening and hearing loss diagnosis 
for neonates treated in an intensive care unit and/or 
intermediate care setting at Prof Dr. José Aristodemo 
Pinotti CAISM Hospital.
METHOD
This cross-sectional prospective trial was 
approved by the Ethics in Research Committee - 
School of Medical Sciences, University of Campinas 
(FCM/Unicamp) and was given permit 1.085/2009. 
Subjects were enrolled voluntarily and their parents 
signed an informed consent term for their participation.
The study included neonates seen in the ICU 
and/or intermediate care center at CAISM Hospital with 
stays lasting for 48 hours and more within a period 
of 13 months, between March of 2011 and March of 
2012. Children born in other services, and patients who 
died or failed to complete all the stages of the study 
were excluded. Initially, the risk indicators on the JCIH 
and COMUSA1,2 were analyzed for each patient, along 
with their personal identification information, data 
on their birth status, and patient charts. Automated 
monitoring of brainstem auditory evoked potentials 
(Accuscreen - GN Otometrics) was used in the auditory 
screening of neonates as they were about to be 
discharged. Auditory screening sessions were held four 
times a week - on Mondays, Wednesdays, Thursdays, 
and Fridays - in the newborn care room. Referred infants 
and individuals unable to be tested were screened 
after discharge in appointments set by the medical 
team. Patients responding to clicks of 35 dB bilaterally 
were considered to have performed well. The children 
who failed to respond were referred for audiological, 
otorhinolaryngological, and genetic testing.
Audiological assessment was carried out at the 
pediatric audiological diagnosis laboratory at Unicamp 
Cepre Pediatric Diagnostics Lab, FCM, Unicamp in a 
sound proof room. The test included the following 
steps: interview, middle ear examination, and BAEPs 
(i.e., electrophysiological thresholds and auditory 
pathway integrity), in addition to transient otoacoustic 
emissions (TOAEs) and/or distortion product otoacoustic 
emissions (DPOAEs). The patients were sleeping during 
the administration of the test procedures.
Electrophysiological thresholds, as well as auditory 
pathway integrity, were assessed through BAEPs on 
an Interacoustics Eclipse EP 25 with patients wearing 
ear buds. Auditory pathway integrity was tested with 
non-variable 80-dB clicks, to allow the assessment of the 
auditory pathway to the brainstem and identify possible 
alterations in its course. Electrophysiological thresholds 
were captured by offering patients stimuli at decreasing 
intensities until the V wave was triggered, using click 
and tone burst stimuli at 500 and 1,000 Hz. Stimulation 
was repeated twice to verify the reproducibility of the 
tracings and the presence of response. Responses were 
captured through surface electrodes with electrolytic 
paste placed on the right and left mastoid and on the 
frontoparietal position. Patients had their skin cleaned 
with abrasive paste on the sites on which electrodes 
were placed. The following parameters were analyzed: 
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presence of waves I, III, and V; absolute latency of 
waves I, III, and V; interpeak latency I-V, I-III, III-V; 
amplitude of wave V in relation to amplitude of wave 
I; interaural differences in I-V interpeak latency or wave 
V latency. TOAEs and DPOAEs were captured using 
device ILO 292 USBII.
Middle ear status was assessed through otoscopic 
examination (to verify whether patients were able to 
undergo impedance testing), tympanogram tracing, and 
ipsilateral acoustic reflex from 500 to 4,000 Hz, with 
the tone in the transducer set at 1,000 Hz. Impedance 
tests were carried out on a 235H-Interacoustics device.
The responses obtained in the tests were recorded 
in a sheet. Normal hearing was attributed to infants with 
electrophysiological thresholds equal to or under 30 dB 
and absolute and interpeak latencies within the values 
expected for the subjects’ ages and responses within 
expected ranges for the remaining test procedures.
Patients with altered audiological test results were 
referred to an ENT physician for physical examination 
and imaging tests.
The team’s genet ic is t  tes ted neonates 
underperforming in the screening tests by collecting 
DNA from the oral mucosa according to the protocol 
adopted in Laboratory Unicamp Cepre Pediatric 
Diagnostics Lab, FCM, Unicamp. DNA samples were 
collected by the examiner after the completion of 
the auditory tests. Oral mucosa DNA was used to 
analyze mutation 35delG by AS-PCR as standardized 
by the Human Molecular Genetics Lab at CBMEG 
(patent nº P10005340-6; testing method for hearing 
loss of genetic origin). PCR was used to analyze 
deletions D(GJB6-D13S1830) and D(GJB6-D13S1854) 
using previously described primers6. Mitochondrial 
mutations were analyzed through the amplification 
of DNAmt fragments from gene 12S rRNA to detect 
mutations A1555G, C1494T, A827G, using previously 
described primer pairs. The product of amplification 
was submitted to restriction analysis to detect mutations.
The data collected from patient charts and the 
results from auditory screening tests were recorded in an 
information system. These data sets were used to build des-
criptive charts and to further statistically analyze the results.
RESULTS
A total of 526 children stayed in the ICU and/or 
intermediate care unit at CAISM/Unicamp University 
Hospital for at least 48 hours between March of 2011 and 
March of 2012. Thirty-seven individuals died, yielding 
Table 1. Auditory screening results of the neonates in the 
CAISM neonatal ICU and intermediate care facility.
Auditory Screening n %
Yes 414 84.7
No 75 15.3
Total 489 100
Yes/Pass 337 81.4
Failed 35 dB 4 0.96
Failed 40 dB 19 4.6
Failed 45 dB 54 13.04
Table 2. Age (days) at which screening tests were carried out.
Age n %
< 30 days 243 60
30 to 60 days 85 21
> 60 days 77 19
Mean = 36.6 days.
489 live births; 53.2% were boys, 67% were preterm 
births, 44% weighed less than 2,000 g, and 20% had 
very light weight at birth (< 1500g); 59% had two to 
four risk factors for hearing loss.
Table 1 shows the results of neonatal auditory 
screening tests.
No statistically significant difference was seen 
when pass/fail statuses and gender (p = 0.3963), 
gestational age (p = 0.3448), weight (p = 0.3291), 
number of risk factors (p = 0.4826), or age after birth 
at which the tests were carried out (p = 0.1654) were 
analyzed. Among risk factors, only hyperbilirubinemia 
was statistically significant in relation to the outcome of 
the auditory screening tests. Two thirds (66.7%) of the 
children with this risk factor failed auditory screening 
(p = 0.0002).
Table 2 shows the number of days after birth at 
which the individuals underwent auditory screening.
The subjects who failed screening tests were 
referred for diagnosis. Fifty-seven percent of the 
individuals (44/77) completed the required diagnostic 
tests. The other patients were excluded from the 
program for not having completed the process after 
four attempts of scheduling visits for them.
Table 3 shows the results from the combined 
analysis of audiological and otorhinolaryngological tests.
Mutation 35delG in the connexin 26 gene (GJB2) 
or deletions D(GJB6-D13S1830) and Δ(GJB6-D13S1854) 
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the tested function7. Neonates in ICU settings usually 
have more than one risk factor, many of which 
conducive to hearing loss. Consequently, the incidence 
of hearing loss in this population is higher - from 1% 
to 4%8. Automated BAEP monitoring is a recommended 
screening procedure that assesses the auditory system 
to the brainstem and uses statistical criteria to pass or 
fail patients in the test. Patients pass or fail based on 
their response to click stimuli. The test does not allow 
wave visualization9. It is a highly sensitive (test ability 
to identify hearing loss) and specific (test ability to 
identify individuals as having normal hearing) method10. 
Some authors have rated it as reasonably specific, as 
tests misses out on rare ascending hearing losses and 
conductive hearing loss11.
Auditory screening was done in 84.7% of the 489 
newborns who stayed in the neonatal ICU for 48 hours 
and more (Table 1). The goal was to offer universal 
auditory screening, as described in the JCIH and 
COMUSA1,2. However, some factors made it impossible 
to reach a rate of 95% or greater of screened infants. The 
CAISM is a tertiary care university hospital located in the 
metropolitan areas of Campinas and Piracicaba, an area 
encompassing over 60 municipalities, and a reference 
center for female and neonate health care prepared to 
handle high risk pregnancies due to maternal or fetal 
disease. In order to meet the significant demand for ICU 
services, neonates are often referred to other centers for 
care. This particularity pertaining to our service made 
it impossible for some neonates to undergo auditory 
screening, as they were using devices that interfered 
with the equipment needed to perform screening tests.
In many cases screening was not indicated for 
the risk neonates were of having their auditory systems 
impaired due to ototoxic drugs or factors connected with 
the transference of patients to other institutions. The 
study’s staff attempted to schedule the patients initially 
unavailable for screening to undergo testing at a later 
time, but many refused to show up despite our efforts. 
Many neonates discharged during weekends - when 
screening tests were not offered - were also lost.
In order to increase the number of screened 
neonates to cover 95% or more of them, it is 
recommended, whenever possible, to perform screening 
tests before patients are discharged to minimize the 
possibility of subjects missing their scheduled visits. To 
do so, it is recommended that a speech and hearing 
therapist be hired for at least 20 hours a week and to 
work on call during weekends. Another factor that 
may improve compliance with auditory screening is 
providing counseling to the families of the neonates, 
so they are informed of the importance of hearing in 
Table 3. Audiological and otorhinolaryngological diagnosis of 
the children who failed the auditory screening tests.
Diagnosis n %
Normal hearing 28 63.8
Conductive hearing loss 9 20.4
Sensorineural hearing loss 6 13.6
Auditory neuropathy spectrum disorder 1 2.2
Total 44 100
Table 4. Main study findings for the enrolled population.
Results n %
Passed Screening 337 81.4
Failed Auditory 77 18.6
Total 414 100
Auditory diagnosis Normal 28 63.8
CHL 9 20.4
SNHL 6 13.6
ANSD 1 2.2
Total 44 100
Incidence CHL 9/414 2.2
SNHL 6/414 1.4
ANSD 1/414 0.24
CHL + SNHL + ANSD 16/414 3.84
CHL: Conductive hearing loss; SNHL: Sensorineural hearing loss; 
ANSD: Auditory neuropathy spectrum disorder.
in gene GJB6 were not seen in the genetic tests 
performed on the 44 patients who failed auditory 
screening tests. Two children had mutation A1555G 
in mitochondrial gene MTRNR. These children had 
normal hearing.
Table 4 shows the incidence of hearing loss in 
the studied sample.
No statistically significant difference was seen 
when diagnosis of normal hearing and hearing loss were 
considered vis-à-vis gender (p = 0.3477), gestational age 
(p = 0.2523), weight (p = 0.2491), and number of risk 
factors (p = 0.067). Statistically significant difference 
was seen (p = 0.002) between failed auditory screening 
tests for 35, 40, and 45 dB and patient diagnosis. Most 
of the children (90.9%) who failed the test at 40 dB had 
normal hearing.
DISCUSSION
Neonatal auditory screening is the most significant 
tool in the early detection of hearing loss. The procedure 
must be quick, simple, and able to select the patients 
with the highest probability of having alterations for 
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the development of speech and language and the role 
of auditory screening in the early detection of hearing 
loss, and the relevance of showing up in the scheduled 
date to have their children undergo the screening tests. 
A poll done with 35 parents and guardians of pediatric 
ICU patients revealed that approximately 80% of the 
them had never heard about auditory screening, its use, 
or the importance of hearing12. Other studies will be 
carried out to verify whether auditory health education 
for parents and expecting mothers could increase 
program compliance.
In Brazil, several studies have failed to attain 
95% compliance in neonatal auditory screening13-15. 
No epidemiological studies were found on overall 
compliance rates of auditory screening programs in 
Brazil, but studies are known to be concentrated in 
large centers and maternity hospitals, albeit to a much 
lesser degree. Federal Law 12303 as of August 2, 201016, 
which made it mandatory for all hospitals and maternity 
hospitals to offer evoked otoacoustic emissions testing 
free of charge to all children born in their premises, 
and the Guidelines for Neonatal Auditory Care and 
Screening published in 201217 are expected to positively 
change this scenario.
Most of the children passed the auditory screening 
test, i.e., they responded to 35-dB bilateral click stimuli 
on BAEP testing. Overall failure rate was 18.6%, which 
was above the rates published in the literature; most 
subjects failed at 45 dB (Table 1). Such high failure rate 
was due to the lack of experience the team had using a 
new testing device, and possibly other factors as well, 
such as the high rate at which the device presented click 
stimuli (55 Hz) and the automated response analysis 
feature, as in preterm babies latencies may be different 
than the norm. Additionally, the difficulties placing the 
electrodes and fitting the ear buds in the narrow ear 
canals of the children may have increased the number 
of failed test results.
Future studies will be carried out to eliminate the 
impact of lack of experience with the device so that 
other possible causes of failure are singled out.
An analysis of the age at which auditory screening 
was carried out revealed that 21.1% of the children were 
tested between 30 and 60 days of age and 18.6% after 
60 days of age (Table 2). Auditory screening should be 
carried out close to the time of discharge, after newborns 
have overcome the possible adverse events connected 
to prenatal, perinatal, and post-natal care and when they 
no longer need to be in an incubator, on life support, or 
medications. According to the JCIH1 and the COMUSA2, 
screening should be performed by the first month of life, 
hearing loss should be diagnosed by the third month 
of life, and fitting of hearing aids should occur by the 
sixth month of life. These recommendations do not 
apply to many of the neonates staying at ICUs, as they 
often require hospitalization for over 60 days.
The children who passed the screening tests and 
had risk factors for progressive and/or late onset hearing 
loss were referred for hearing and language monitoring 
at 6, 12, 18, and 24 months of age. This measure aimed 
to detect possible cases of ascending or conductive 
hearing loss in patients who passed the screening tests.
The patients who failed the screening tests 
were referred for diagnosis. Audiological and 
otorhinolaryngological tests revealed that 63.8% (28/44) 
of the subjects had normal hearing. Hearing loss 
was observed in 36% (16/44) of the children; 20.4% 
(9/44) had conductive hearing loss; 13.6% (6/44) had 
sensorineural hearing loss; and 2.2%(1/44) had auditory 
neuropathy spectrum disorder (Table 3).
Most of the children who failed the screening tests 
had normal results in the hearing tests applied. There 
was a high rate of false positive results, i.e., children 
failing the auditory screening tests were deemed to have 
normal hearing in diagnostic evaluation. Automated 
monitoring of BAEPs in auditory screening has been 
claimed to reduce the need to refer patients to diagnostic 
assessment. The reduced rates reported in the literature 
are based on a two-stage auditory screening process 
(test-retest)18,19. More familiarity with the screening 
equipment, combined to retesting, may substantially 
reduce the rate of false positive results and the number 
of patients lost in follow-up and normal results, in 
addition to minimizing parental stress and anxiety with 
the outcomes of auditory screening tests. National and 
international science committees do not support the 
retesting of populations at risk; rather, they should be 
immediately referred to diagnostic examination1,2.
Forty-three percent of the patients referred to 
diagnostic evaluation were lost in follow-up. Patient 
evasion in auditory health programs is a global reality. 
Compliance to auditory health programs must be 
improved to allow the early detection of individuals with 
hearing loss. Factors such as low number of prenatal 
care visits (one to three), having more than one child, 
being a single parent, and mothers with low levels of 
education impact infant health program compliance 
rates. It has been recommended that topics concerning 
the relevance of hearing for the development of children 
and the possibility of detecting early cases be discussed 
during prenatal care visits, so that parents become 
aware of the facts to consider on infant deafness and its 
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adverse impacts. The importance of neonatal auditory 
screening should be more communicated to patients, 
health care workers, and pediatricians in particular, as 
neonates are part of the audience they serve, so as to 
encourage patient attendance to screening tests.
The incidence of hearing loss in the studied 
sample was of approximately 4%; 1.4% of the subjects 
had sensorineural hearing loss, 0.24% had auditory 
neuropathy spectrum disorder, and 2.2% had conductive 
hearing loss (Table 4). The incidence rates published 
in the literature usually cover sensorineural hearing 
loss. Reported incidence rates among neonates in ICU 
settings range between 1% and 4%1,2,11,20,21, as also found 
in our study. The same was observed for auditory 
neuropathy spectrum disorder, with rates ranging from 
0.2% to 4%22-24.
Genetic assays showed patients were normal 
for mutation 35delG in the connexin 26 (GJB2) gene. 
Although none of the individuals had mutation 35delG, 
it is present in 70% of the individuals with hearing loss 
in whom gene GJB2 is involved. A prevalence of 0.97% 
has been reported in Brazil for mutation 35delG, a rate 
of 1:103 heterozygotes, in a screening initiative carried 
out with 620 neonates in the region of Campinas25. In 
addition to gene GJB2, deletions Δ(GJB6-D13S1830) 
and Δ(GJB6-D13S1854) on gene GJB6 were screened 
for. None of the individuals enrolled in this study 
had the aforementioned deletions. Screening was 
also done for mitochondrial mutation A1555G, with 
described associations with hearing loss and use of 
aminoglycosides. Two children had mutation A1555G 
on mitochondrial gene MTRNR, and both had normal 
hearing. The negative test results for the studied gene 
mutations reduce the empirical risk related to a genetic 
etiology for hearing loss.
The children diagnosed with conductive hearing 
loss are being followed by the team’s ENT physician 
and, whenever needed, they are referred for audiological 
evaluation. They will be followed by a multidisciplinary 
team, as the impact of conductive hearing loss upon 
the development of hearing, language, and school 
performance has been established. The patients with 
sensorineural hearing loss are currently having hearing 
aids fitted (conventional aids or cochlear implants) and 
speech and hearing rehabilitation.
The correlation between the studied variables and 
failure in auditory screening tests was not statistically 
significant. When risk factors are considered, only 
hyperbilirubinemia significantly affected the outcome 
of auditory screening tests. Diagnosis was statistically 
correlated with failing screening tests at 35, 40, 45 dB. 
Most of the children (90.9%) who failed the tests at 40 
dB had normal hearing. More studies will be carried out 
to increase the size of the sample and verify this finding. 
The low number of children diagnosed with hearing 
loss may have affected the test results. The literature 
indicates higher incidences of hearing loss in children 
weighing 1,500 g and less and preterm babies26-28.
CONCLUSION
The analysis of the results of this study indicated 
it was not possible to offer universal neonatal auditory 
screening in the studied sample or to screen patients 
within their first 30 days of life, given the long time 
for which neonates stay in intensive care. Whenever 
possible, auditory screening should be carried out 
before discharge. One-stage auditory screening led to a 
significant number of false-positive results. The overall 
incidence of hearing loss was 4%, including cases of 
sensorineural and conductive hearing loss, and auditory 
neuropathy spectrum disorder.
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